ADRA2B anticorps
Aperçu rapide pour ADRA2B anticorps (ABIN5699177)
Antigène
Voir toutes ADRA2B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Immunogène
- adrenergic, alpha-2B-, receptor
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB :1:200-1:1000,IHC:1:50-1:500
-
Commentaires
-
mouse brain tissue were subjected to SDS PAGE followed by western blot with FNab00179(ADRA2B-Specific antibody) at dilution of 1:100
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze / thaw cycles.
-
Stock
- -20 °C
-
Date de péremption
- 12 months
-
-
- ADRA2B (Adrenergic, alpha-2B-, Receptor (ADRA2B))
-
Autre désignation
- ADRA2B
-
Sujet
- ADRA2B, also named as ADRA2L1 and ADRA2RL1, belongs to the G-protein coupled receptor 1 family. ADRA2B mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The antibody is specific to ADRA2B.
-
Poids moléculaire
- 50kDa
-
UniProt
- P18089
-
Pathways
- EGFR Signaling Pathway, cAMP Metabolic Process
Antigène
-